Carotid intima thickness and cardiovascular risk assessment in patients treated for head and neck cancer
Cardiovascular disease (CVD) is the leading cause of non–cancer-related morbidity and mortality among patients treated for head and neck cancer (HNC). However, the extent to which these patients are screened for CVD remains unclear, and the long-term impact of different anticancer treatment modalities for HNC on...